ORAVERSE 400 micrograms/1.7 ml, solution for injection 10 cartridges of 1.7 ml
Active ingredients: Phentolamine mesylate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 cartridges of 1.7 mldentaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ORAVERSE 400 microgrammes/1,7 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- dentaire
- Presentation description
- 10 cartouche(s) en verre de 1,7 ml
- Marketing authorisation holder
- SEPTODONT HOLDING
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68844504CIP72195835CIP133400921958355Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSILATE DE PHENTOLAMINEsolution | 400 microgrammes · 1,7 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.